Colin D Marchant
Affiliation: Boston University
- Randomized trial to assess immunogenicity and safety of Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine in infantsColin D Marchant
Boston University Medical Center, Boston, MA 02118, USA
Pediatr Infect Dis J 29:48-52. 2010..Study assessed the immunogenicity and safety of an investigational Haemophilus influenzae type b-Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine (HibMenCY-TT) in infants...
- Prevalence and genetic diversity of nontypeable haemophilus influenzae in the respiratory tract of infants and primary caregiversSandra K Schumacher
Department of Pediatric Infectious Diseases, Boston University Medical Center, Boston, MA 02118, USA
Pediatr Infect Dis J 31:145-9. 2012..Colonization, strain diversity, transmission, and antimicrobial susceptibility have implications for both children and their caregivers...
- Effectiveness of Centers for Disease Control and Prevention recommendations for outcomes of acute otitis mediaHoward Bauchner
Department of Pediatrics, Boston University School of Medicine, Boston, Massachusetts, USA
Pediatrics 117:1009-17. 2006....
- Seven valent pneumococcal conjugate vaccine immunization in two Boston communities: changes in serotypes and antimicrobial susceptibility among Streptococcus pneumoniae isolatesStephen I Pelton
Department of Pediatrics, Boston University School of Medicine and Boston Medical Center, Boston, MA, USA
Pediatr Infect Dis J 23:1015-22. 2004..Seven valent pneumococcal conjugate vaccine (PCV7) was licensed and introduced in 2000 for universal administration of children younger than 2 years of age and for selective immunization of children 2-5 years of age...
- Fluoroquinolone use in childrenVishakha Sabharwal
Boston Medical Center, Boston, MA, USA
Pediatr Infect Dis J 25:257-8. 2006